PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Global Market Research indicates price for Zilosu, page-51

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 478 Posts.
    lightbulb Created with Sketch. 130
    CSL is $312 a share par is $2.30 share just look at what we know now and remember it's a repurposed drug quite possibly the greatest buying opportunity ever
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.